Importantly, we found that inflammatory CAFs (iCAFs) enhance tumor stemness by upregulating SOX9 and OLFM4, contributing to drug resistance and cell proliferation through the AREG‐ERBB2 signaling pathway. This evidence concerns the gene ERBB2 and neoplasm.